Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 13.80 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 2.80 Billion EUR for the item "Net Income Applicable To Common Shares" represents a decrease of -51.79 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 2.80 Billion EUR for the item "Net Income Applicable To Common Shares" represents a decrease of -0.46 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 13.80 Billion EUR for the item "Net Income Applicable To Common Shares" represents a decrease of -0.09 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 206.26 percent compared to the value the year prior.
The 1 year change in percent is 206.26.
The 3 year change in percent is 115.93.
The 5 year change in percent is 22.96.
The 10 year change in percent is 160.77.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Applicable To Common Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |